Plasma Phospholipid Fatty Acids and Prostate Cancer Risk in the SELECT Trial.

Publication Type:

Journal Article


Journal of the National Cancer Institute, Volume 105, Issue 15, p.1132-1141 (2013)


2013, August 2013, Public Health Sciences Division


Studies of dietary ω-3 fatty acid intake and prostate cancer risk are inconsistent; however, recent large prospective studies have found increased risk of prostate cancer among men with high blood concentrations of long-chain ω-3 polyunsaturated fatty acids ([LCω-3PUFA] 20:5ω3; 22:5ω3; 22:6ω3]. This case-cohort study examines associations between plasma phospholipid fatty acids and prostate cancer risk among participants in the Selenium and Vitamin E Cancer Prevention Trial.